Phase I trial to investigate ascending multiple doses of FV 100 in volunteers.

Trial Profile

Phase I trial to investigate ascending multiple doses of FV 100 in volunteers.

Completed
Phase of Trial: Phase I

Latest Information Update: 03 May 2009

At a glance

  • Drugs Valnivudine (Primary)
  • Indications Herpes zoster
  • Focus Adverse reactions; Pharmacokinetics
  • Most Recent Events

    • 10 Feb 2009 Results reported by Inhibitex. Results will be presented at a scientific conference later in 2009.
    • 10 Feb 2009 Status changed from recruiting to completed as reported by Inhibitex.
    • 29 Apr 2008 The Investigational New Drug application for FV 100 has been accepted by the FDA, reported Inhibitex.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top